AACAP Physician Scientist Program in Substance Use

AACAP 药物使用医师科学家计划

基本信息

  • 批准号:
    10366880
  • 负责人:
  • 金额:
    $ 38.63万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-01-01 至 2025-05-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY / ABSTRACT This supplement request will support the enrollment of additional scholars in the American Academy of Child and Adolescent Psychiatry (AACAP) Physician Scientist Program in Substance Use. This additional support will increase the diversity of the cohort thereby promoting underrepresented physicians engaging in substance use research. Most mental and substance use disorders emerge during childhood and adolescence, but they are rarely recognized or addressed until adulthood. With specialized training in developmental psychopathology, child and adolescent psychiatrists are ideally suited to address these disorders before adulthood to reduce associated morbidity and mortality. While it is clearly recognized that substance use complicates the course of mental disorders, few child and adolescent psychiatrists receive specialized training to address substance use disorders, and exceedingly few pursue careers in research to advance substance use disorder prevention and treatment. Established in 1998, the AACAP Physician Scientist Program in Substance Use addresses this critical shortage by delivering a highly structured clinical research training and career development program for outstanding child and adolescent psychiatrists with the potential to make significant impacts on adolescent substance use disorder prevention and treatment. Since its inception, the program has successfully cultivated the careers of 24 child and adolescent psychiatrist physician-scientists. Twenty-three of the 24 scholars have established or are well on their way to establishing careers in substance use-related research. AACAP remains an ideal institutional home for the K12 given its strong institutional commitment, ample resources, and membership that includes more than 95% of child and adolescent psychiatrists in the country, including all current and former K12 scholars. AACAP has pledged its continued commitment and support of scholars’ career development. Additionally, K12 scholars’ research presentations at the AACAP Annual Meetings facilitate and accelerate the pace of translation from research to practice, clearly impacting the field. The program is making important progress, but more work is needed, as fewer than 2% of child and adolescent psychiatrists are significantly involved in research, and even fewer have established careers in substance use-related research. This administrative supplement will serve to enhance the success of the program’s overarching aims. Aim 1: To increase the number of independently funded child and adolescent psychiatrist addiction researchers. Aim 2: To expand the network of senior mentors, academic centers, and addiction research training opportunities for K12 scholars and other early career investigators. An unprecedentedly large, highly qualified, and diverse group of child and adolescent psychiatrist candidates have applied for scholar positions in the upcoming cohort. Engaging an expanded cohort of promising scholars in the program will catalyze their careers and yield significant impacts on the field, advancing science and clinical practice to reduce the societal burden of substance use disorders.
项目摘要/摘要 这项补充申请将支持在美国儿童学院招收更多学者 和青少年精神病学(AACAP)物质使用方面的内科科学家计划。这一额外的支持将 增加队列的多样性,从而促进未被充分代表的医生从事药物使用 研究。大多数精神和物质使用障碍出现在童年和青春期,但它们是 在成年之前很少被认出或被提及。接受过发展精神病理学方面的专门训练, 儿童和青少年精神病学家非常适合在成年前解决这些障碍,以减少 相关的发病率和死亡率。虽然人们清楚地认识到,物质使用会使 在精神障碍方面,很少有儿童和青少年精神病学家接受针对药物使用的专门培训 精神障碍,极少数人从事研究以促进物质使用障碍的预防和 治疗。AACAP在物质使用方面的医师科学家计划成立于1998年,旨在解决这一关键问题 通过提供高度结构化的临床研究培训和职业发展计划来弥补短缺 有潜力对青少年产生重大影响的杰出儿童和青少年精神病学家 物质使用障碍的防治。自成立以来,该计划成功地培养了 24名儿童和青少年精神病学家、内科医生和科学家的职业生涯。24位学者中有23位 在与物质使用相关的研究方面已经或正在很好地建立职业生涯。AACAP遗体 鉴于K12强大的机构承诺、充足的资源和 成员包括全国95%以上的儿童和青少年精神病学家,包括所有现有的 和前K12学者。AACAP承诺继续致力于并支持学者的职业生涯 发展。此外,K12学者在AACAP年会上的研究报告促进和 加快翻译从研究到实践的步伐,明显影响着领域。节目正在制作中 取得了重要进展,但还需要做更多的工作,因为只有不到2%的儿童和青少年精神病学家 主要从事研究的人数较少,从事与物质使用有关的研究的人数更少。 这一行政补充将有助于加强该方案总体目标的成功。目标1:实现 增加独立资助的儿童和青少年精神病学家成瘾研究人员的数量。目标2:实现 扩展K12的高级导师、学术中心和成瘾研究培训机会网络 学者和其他早期职业研究者。史无前例的庞大、高素质和多样化的群体 儿童和青少年精神病学家候选人已经申请了即将到来的队列中的学者职位。引人入胜 该项目中一批有前途的学者的扩大将促进他们的职业生涯并产生重大影响 在实地,推动科学和临床实践,以减少物质使用障碍的社会负担。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kevin M Gray其他文献

Nicotine Therapy Sampling to Induce Quit Attempts Among Smokers Unmotivated to Quit
尼古丁治疗取样以诱导无戒烟动机的吸烟者尝试戒烟
  • DOI:
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    0
  • 作者:
    M. Carpenter;John R. Hughes;Kevin M Gray;A. Wahlquist;M. Saladin;A. Alberg
  • 通讯作者:
    A. Alberg

Kevin M Gray的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kevin M Gray', 18)}}的其他基金

A Proof-of-Concept Trial of N-Acetylcysteine for Adolescent Alcohol Use Disorder
N-乙酰半胱氨酸治疗青少年酒精使用障碍的概念验证试验
  • 批准号:
    10480914
  • 财政年份:
    2018
  • 资助金额:
    $ 38.63万
  • 项目类别:
A Proof-of-Concept Trial of N-Acetylcysteine for Adolescent Alcohol Use Disorder
N-乙酰半胱氨酸治疗青少年酒精使用障碍的概念验证试验
  • 批准号:
    10241372
  • 财政年份:
    2018
  • 资助金额:
    $ 38.63万
  • 项目类别:
A Proof-of-Concept Trial of N-Acetylcysteine for Adolescent Alcohol Use Disorder
N-乙酰半胱氨酸治疗青少年酒精使用障碍的概念验证试验
  • 批准号:
    9789787
  • 财政年份:
    2018
  • 资助金额:
    $ 38.63万
  • 项目类别:
13/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT MUSC
13/21 ABCD-美国联盟:MUSC 研究项目现场
  • 批准号:
    10596593
  • 财政年份:
    2017
  • 资助金额:
    $ 38.63万
  • 项目类别:
N-Acetylcysteine and Contingency Management for Youth Cannabis Use Disorder
N-乙酰半胱氨酸和青少年大麻使用障碍的应急管理
  • 批准号:
    9156301
  • 财政年份:
    2017
  • 资助金额:
    $ 38.63万
  • 项目类别:
N-Acetylcysteine and Contingency Management for Youth Cannabis Use Disorder
N-乙酰半胱氨酸和青少年大麻使用障碍的应急管理
  • 批准号:
    10087909
  • 财政年份:
    2017
  • 资助金额:
    $ 38.63万
  • 项目类别:
13/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT MUSC
13/21 ABCD-美国联盟:MUSC 研究项目现场
  • 批准号:
    9981294
  • 财政年份:
    2017
  • 资助金额:
    $ 38.63万
  • 项目类别:
13/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT MUSC
13/21 ABCD-美国联盟:MUSC 研究项目现场
  • 批准号:
    10379329
  • 财政年份:
    2017
  • 资助金额:
    $ 38.63万
  • 项目类别:
Advancing Varenicline as a Treatment for Cannabis Use Disorder
推进伐尼克兰治疗大麻使用障碍
  • 批准号:
    9249775
  • 财政年份:
    2016
  • 资助金额:
    $ 38.63万
  • 项目类别:
Advancing Varenicline as a Treatment for Cannabis Use Disorder
推进伐尼克兰治疗大麻使用障碍
  • 批准号:
    10202536
  • 财政年份:
    2016
  • 资助金额:
    $ 38.63万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 38.63万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 38.63万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.63万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.63万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 38.63万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.63万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 38.63万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 38.63万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 38.63万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.63万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了